共 211 条
[1]
Marusyk A(2020)Intratumor heterogeneity: the rosetta stone of therapy resistance Cancer Cell 37 471-484
[2]
Janiszewska M(2016)Radiomics: images are more than pictures, they are data Radiology 278 563-577
[3]
Polyak K(2014)Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach Nat Commun 5 4006-1211
[4]
Gillies RJ(2014)Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance Clin Cancer Res 20 1204-1259
[5]
Kinahan PE(2017)Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma Ann Oncol 28 1250-1470
[6]
Hricak H(2015)Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma J Clin Invest 125 1459-755
[7]
Aerts HJ(2013)A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer Nat Genet 45 747-20
[8]
Velazquez ER(2017)Co-clinical quantitative tumor volume imaging in ALK-rearranged NSCLC treated with crizotinib Eur J Radiol 88 15-1683
[9]
Leijenaar RT(2016)Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer J Transl Med 14 111-113281
[10]
Parmar C(2015)The future of patient-derived tumor xenografts in cancer treatment Pharmacogenomics 16 1671-1520